Novartis (NVS) is seeking a judicial review in the U.K. to stop some hospitals in the south from...

|About: Novartis AG (NVS)|By:, SA News Editor

Novartis (NVS) is seeking a judicial review in the U.K. to stop some hospitals in the south from using Roche's (RHHBY.PK) Avastin for treating AMD, a common cause of blindness that's usually treated with Novartis' blockbuster Lucentis drug. Avastin is much cheaper, but hasn't been licensed for AMD and has more side effects.